Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

VEGF and its receptor might cause hair loss.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Early onset hair loss linked to genetics and androgen levels.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.